Literature DB >> 33322198

Possible Transmission Flow of SARS-CoV-2 Based on ACE2 Features.

Sk Sarif Hassan1, Shinjini Ghosh2, Diksha Attrish3, Pabitra Pal Choudhury4, Alaa A A Aljabali5, Bruce D Uhal6, Kenneth Lundstrom7, Nima Rezaei8,9, Vladimir N Uversky10, Murat Seyran11, Damiano Pizzol12, Parise Adadi13, Antonio Soares14, Tarek Mohamed Abd El-Aziz14,15, Ramesh Kandimalla16,17, Murtaza M Tambuwala18, Gajendra Kumar Azad19, Samendra P Sherchan20, Wagner Baetas-da-Cruz21, Kazuo Takayama22, Ángel Serrano-Aroca23, Gaurav Chauhan24, Giorgio Palu25, Adam M Brufsky26.   

Abstract

Angiotensin-converting enzyme 2 (ACE2) is the cellular receptor for the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) that is engendering the severe coronavirus disease 2019 (COVID-19) pandemic. The spike (S) protein receptor-binding domain (RBD) of SARS-CoV-2 binds to the three sub-domains viz. amino acids (aa) 22-42, aa 79-84, and aa 330-393 of ACE2 on human cells to initiate entry. It was reported earlier that the receptor utilization capacity of ACE2 proteins from different species, such as cats, chimpanzees, dogs, and cattle, are different. A comprehensive analysis of ACE2 receptors of nineteen species was carried out in this study, and the findings propose a possible SARS-CoV-2 transmission flow across these nineteen species.

Entities:  

Keywords:  ACE2; SARS-CoV-2; bioinformatics; transmission; viral spike receptor-binding domain

Mesh:

Substances:

Year:  2020        PMID: 33322198      PMCID: PMC7763092          DOI: 10.3390/molecules25245906

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  42 in total

1.  The NCBI. Publicly available tools and resources on the Web.

Authors:  J P Jenuth
Journal:  Methods Mol Biol       Date:  2000

2.  Twilight zone of protein sequence alignments.

Authors:  B Rost
Journal:  Protein Eng       Date:  1999-02

3.  Exploiting heterogeneous sequence properties improves prediction of protein disorder.

Authors:  Zoran Obradovic; Kang Peng; Slobodan Vucetic; Predrag Radivojac; A Keith Dunker
Journal:  Proteins       Date:  2005

4.  Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals.

Authors:  Yuan Liu; Zhi Ning; Yu Chen; Ming Guo; Yingle Liu; Nirmal Kumar Gali; Li Sun; Yusen Duan; Jing Cai; Dane Westerdahl; Xinjin Liu; Ke Xu; Kin-Fai Ho; Haidong Kan; Qingyan Fu; Ke Lan
Journal:  Nature       Date:  2020-04-27       Impact factor: 49.962

5.  Angiotensin-Converting Enzyme 2 (ACE2) Is a Key Modulator of the Renin Angiotensin System in Health and Disease.

Authors:  Chris Tikellis; M C Thomas
Journal:  Int J Pept       Date:  2012-03-20

Review 6.  COVID-19: Epidemiology, Evolution, and Cross-Disciplinary Perspectives.

Authors:  Jiumeng Sun; Wan-Ting He; Lifang Wang; Alexander Lai; Xiang Ji; Xiaofeng Zhai; Gairu Li; Marc A Suchard; Jin Tian; Jiyong Zhou; Michael Veit; Shuo Su
Journal:  Trends Mol Med       Date:  2020-03-21       Impact factor: 11.951

7.  Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV.

Authors:  Ming Zheng; Lun Song
Journal:  Cell Mol Immunol       Date:  2020-03-04       Impact factor: 11.530

8.  Infection of dogs with SARS-CoV-2.

Authors:  Thomas H C Sit; Christopher J Brackman; Sin Ming Ip; Karina W S Tam; Pierra Y T Law; Esther M W To; Veronica Y T Yu; Leslie D Sims; Dominic N C Tsang; Daniel K W Chu; Ranawaka A P M Perera; Leo L M Poon; Malik Peiris
Journal:  Nature       Date:  2020-05-14       Impact factor: 49.962

9.  Integrate structural analysis, isoform diversity, and interferon-inductive propensity of ACE2 to predict SARS-CoV2 susceptibility in vertebrates.

Authors:  Eric R Sang; Yun Tian; Yuanying Gong; Laura C Miller; Yongming Sang
Journal:  Heliyon       Date:  2020-08-31

10.  Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2.

Authors:  Ye Qiu; Yuan-Bo Zhao; Qiong Wang; Jin-Yan Li; Zhi-Jian Zhou; Ce-Heng Liao; Xing-Yi Ge
Journal:  Microbes Infect       Date:  2020-03-19       Impact factor: 2.700

View more
  13 in total

Review 1.  Interferon therapy in patients with SARS, MERS, and COVID-19: A systematic review and meta-analysis of clinical studies.

Authors:  Kiarash Saleki; Shakila Yaribash; Mohammad Banazadeh; Ehsan Hajihosseinlou; Mahdi Gouravani; Amene Saghazadeh; Nima Rezaei
Journal:  Eur J Pharmacol       Date:  2021-06-12       Impact factor: 4.432

2.  Potential antiviral activity of isorhamnetin against SARS-CoV-2 spike pseudotyped virus in vitro.

Authors:  Yingzhuan Zhan; Wenjing Ta; Wenjuan Tang; Ruochen Hua; Jue Wang; Cheng Wang; Wen Lu
Journal:  Drug Dev Res       Date:  2021-04-13       Impact factor: 5.004

Review 3.  Biosensing surfaces and therapeutic biomaterials for the central nervous system in COVID-19.

Authors:  Amene Saghazadeh; Nima Rezaei
Journal:  Emergent Mater       Date:  2021-03-10

Review 4.  Effective drugs used to combat SARS-CoV-2 infection and the current status of vaccines.

Authors:  Annoor Awadasseid; Yanling Wu; Yoshimasa Tanaka; Wen Zhang
Journal:  Biomed Pharmacother       Date:  2021-01-28       Impact factor: 7.419

Review 5.  A systematic review of pregnant women with COVID-19 and their neonates.

Authors:  Mona Mirbeyk; Amene Saghazadeh; Nima Rezaei
Journal:  Arch Gynecol Obstet       Date:  2021-04-02       Impact factor: 2.493

6.  Carbon-Based Nanomaterials: Promising Antiviral Agents to Combat COVID-19 in the Microbial-Resistant Era.

Authors:  Ángel Serrano-Aroca; Kazuo Takayama; Alberto Tuñón-Molina; Murat Seyran; Sk Sarif Hassan; Pabitra Pal Choudhury; Vladimir N Uversky; Kenneth Lundstrom; Parise Adadi; Giorgio Palù; Alaa A A Aljabali; Gaurav Chauhan; Ramesh Kandimalla; Murtaza M Tambuwala; Amos Lal; Tarek Mohamed Abd El-Aziz; Samendra Sherchan; Debmalya Barh; Elrashdy M Redwan; Nicolas G Bazan; Yogendra Kumar Mishra; Bruce D Uhal; Adam Brufsky
Journal:  ACS Nano       Date:  2021-04-07       Impact factor: 15.881

7.  Non-Woven Infection Prevention Fabrics Coated with Biobased Cranberry Extracts Inactivate Enveloped Viruses Such as SARS-CoV-2 and Multidrug-Resistant Bacteria.

Authors:  Kazuo Takayama; Alberto Tuñón-Molina; Alba Cano-Vicent; Yukiko Muramoto; Takeshi Noda; José Luis Aparicio-Collado; Roser Sabater I Serra; Miguel Martí; Ángel Serrano-Aroca
Journal:  Int J Mol Sci       Date:  2021-11-24       Impact factor: 5.923

8.  3D Printed Cobalt-Chromium-Molybdenum Porous Superalloy with Superior Antiviral Activity.

Authors:  Arun Arjunan; John Robinson; Ahmad Baroutaji; Alberto Tuñón-Molina; Miguel Martí; Ángel Serrano-Aroca
Journal:  Int J Mol Sci       Date:  2021-11-24       Impact factor: 5.923

9.  Predicting COVID-19-Comorbidity Pathway Crosstalk-Based Targets and Drugs: Towards Personalized COVID-19 Management.

Authors:  Debmalya Barh; Alaa A Aljabali; Murtaza M Tambuwala; Sandeep Tiwari; Ángel Serrano-Aroca; Khalid J Alzahrani; Bruno Silva Andrade; Vasco Azevedo; Nirmal Kumar Ganguly; Kenneth Lundstrom
Journal:  Biomedicines       Date:  2021-05-17

10.  Special Issue-The Conformational Universe of Proteins and Peptides: Tales of Order and Disorder.

Authors:  Marilisa Leone
Journal:  Molecules       Date:  2021-06-18       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.